Nanostructured lipid carriers as nitroxide depot system measured by electron paramagnetic resonance spectroscopy

Various nanometer scaled transport systems are used in pharmaceutics and cosmetics to increase penetration or storage of actives. Nanostructured lipid carriers (NLCs) are efficient drug delivery systems for dermatological applications. Electron paramagnetic resonance (EPR) spectroscopy was used for...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of pharmaceutics Vol. 421; no. 2; pp. 364 - 369
Main Authors Haag, S.F., Chen, M., Peters, D., Keck, C.M., Taskoparan, B., Fahr, A., Teutloff, C., Bittl, R., Lademann, J., Schäfer-Korting, M., Meinke, M.C.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 15.12.2011
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Various nanometer scaled transport systems are used in pharmaceutics and cosmetics to increase penetration or storage of actives. Nanostructured lipid carriers (NLCs) are efficient drug delivery systems for dermatological applications. Electron paramagnetic resonance (EPR) spectroscopy was used for the determination of TEMPO (2,2,6,6-tetramethyl-1-piperidinyloxy) distribution within the carrier and to investigate the dynamics of skin penetration. Results of ex vivo penetration of porcine skin and in vivo data – forearm of human volunteers – are compared and discussed to previously obtained results with invasomes under comparable conditions. W-band measurements show 35% of TEMPO associated with the lipid compartments of the NLC. Application of TEMPO loaded NLC to skin ex vivo increases the observation time by 12min showing a stabilisation of the nitroxide radical. Moreover, stabilisation is also seen with data generated in vivo. Thus, same as invasomes NLCs are a suitable slow release depot system.
Bibliography:http://dx.doi.org/10.1016/j.ijpharm.2011.10.009
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0378-5173
1873-3476
DOI:10.1016/j.ijpharm.2011.10.009